Jordan Sollof is joined by Richard Scott, chief medical officer, acting CEO and soon to be the new interim CEO of Genomics England, to chat about the work the organisation does and how AI…
Continue Reading
Richard Scott, chief medical officer, acting CEO and soon to be the new interim CEO of Genomics England, has delved deep into the work the organisation does and how AI fits in ahead of…
Continue Reading
Pharmacogenomics has the potential to save money for the health service and contribute to advances in personalised medicine, speakers told a panel at this week’s HETT conference in London, but stakeholders will need to…
Continue Reading
